References
- Vecchio D Ramdas S Munot P Pitt M Beeson D Knight R Paediatric myasthenia gravis: prognostic factors for drug free remission Neuromuscul Disord 2020 Feb 30 2 120 7 https://doi.org/10.1016/j.nmd.2019.11.008 32001147
- Leite MI Jacob S Viegas S Cossins J Clover L Morgan BP IgG1 antibodies to acetylcholine receptors in ‘seronegative’ myasthenia gravis Brain 2008 Jul 131 Pt 7 1940 52 https://doi.org/10.1093/brain/awn092 18515870
- Yan C Li W Song J Feng X Xi J Lu J Cell-Based Versus Enzyme-Linked Immunosorbent Assay for the Detection of Acetylcholine Receptor Antibodies in Chinese Juvenile Myasthenia Gravis Pediatr Neurol 2019 Sep 98 74 9 https://doi.org/10.1016/j.pediatrneurol.2019.01.016 31307830
- Gilhus NE Skeie GO Romi F Lazaridis K Zisimopoulou P Tzartos S Myasthenia gravis - autoantibody characteristics and their implications for therapy Nat Rev Neurol 2016 May 12 5 259 68 https://doi.org/10.1038/nrneurol.2016.44 27103470
- Sanders DB Wolfe GI Benatar M Evoli A Gilhus NE Illa I International consensus guidance for management of myasthenia gravis: executive summary Neurology 2016 Jul 87 4 419 25 https://doi.org/10.1212/WNL.0000000000002790 27358333
DOI: https://doi.org/10.15844/pedneurbriefs-34-24 | Journal eISSN: 2166-6482
Language: English
Page range: 24 - 24
Submitted on: May 1, 2020
Accepted on: Dec 16, 2020
Published on: Dec 24, 2020
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services
© 2020 Jena Krueger, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.